SUPRIYANSE17 March 2025

Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, the details of the Analyst/Investor Meetings to be attended by the Company are as enclosed herewith.

Supriya Lifescience Limited

March 17, 2025 To,

BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 Scrip Code: 543434

Dear Sir/Madam,

National Stock Exchange of India Limited Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex Bandra (E), Mumbai - 400 051 NSE Symbol: SUPRIYA

Subject: Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015

Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited (“Company”) will be interacting with Analyst/Institutional Investors as per details below:

Meeting with

Date & Time

Format

Sr. No. 1.

2.

Stallion Asset Management

Motilal Oswal 11th India Ideation Conference, 2025

Friday, 21 March 2025 between 3:00 PM- 4:00 PM Monday, 24th March 2025 between 10:00 AM- 5:00 PM

2.

MSA Capital Partners

3.

Valcore Capital Advisors

4.

Pi Square Investments

Wednesday, 26 March 2025 between 12:00 Noon - 1:00 PM Wednesday, 26 March 2025 between 2:00 PM- 3:00 PM Thursday, 27 March 2025 between 12:00 Noon- 1:00 PM

Mode

Virtual

In-person

In-person

In-person

Virtual

One-on-one Meeting One-on-one Meeting/ Group Meeting One-on-one Meeting One-on-one Meeting One-on-one Meeting

This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company’s website www.supriyalifescience.com for your information and for the information of your members and the public at large.

This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.

Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund.

Request you to kindly take the same on record.

Thanking you,

For Supriya Lifescience Limited

Prachi Sathe Company Secretary & Compliance Officer

Corporate office

: 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX Tel: +91 22 40332727 / 66942507

CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com

Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com

GOVT. RECOGNISED EXPORT HOUSE

← All TranscriptsSUPRIYA Stock Page →